Lebrikizumab, sold under the brand name Ebglyss is a humanized monoclonal antibody used for the treatment of atopic dermatitis (atopic eczema). It is an...
12 KB (877 words) - 03:57, 17 September 2024
hypereosinophilic leukemia Monoclonal antibodies such as dupilumab and lebrikizumab target IL-13 and its receptor, which reduces eosinophilic inflammation...
29 KB (3,166 words) - 00:19, 9 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
22 KB (1,789 words) - 04:29, 16 July 2024
that use anti-IL-13 monoclonal antibodies include tralokinumab, and lebrikizumab. These treatments have shown improvements in asthma patients, yet there...
20 KB (2,271 words) - 04:25, 12 May 2024
announced its acquisition of Dermira for $1.1 billion, gaining control of lebrikizumab,glycopyrronium cloth used in the treatment of hyperhidrosis, and other...
165 KB (15,040 words) - 23:17, 21 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
202 KB (20,197 words) - 02:19, 22 September 2024
Anrukinzumab Bimekizumab Clazakizumab Gevokizumab Ixekizumab Mirikizumab†Lebrikizumab Olokizumab†Perakizumab Risankizumab Spesolimab Tildrakizumab Veterinary...
38 KB (4,316 words) - 10:24, 26 August 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
74 KB (7,440 words) - 20:50, 21 September 2024
Cintredekin besudotox Interleukin 4 Interleukin 13 Antibodies: Anrukinzumab Lebrikizumab Tralokinumab IL-15 Agonists: ALT-803 Interleukin 15 IL-17 Agonists: Interleukin...
43 KB (3,661 words) - 19:54, 27 August 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
92 KB (9,247 words) - 05:39, 26 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
22 KB (2,243 words) - 21:48, 21 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
47 KB (4,450 words) - 03:22, 28 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
52 KB (5,705 words) - 17:16, 18 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
79 KB (7,694 words) - 01:40, 28 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
181 KB (17,316 words) - 05:17, 7 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
14 KB (1,261 words) - 03:08, 15 September 2024
blockers: Benralizumab Mepolizumab Reslizumab IL-13-specific blockers: Lebrikizumab Tralokinumab Dual IL-4 and IL-13 blockers: Dupilumab IgE-blockers: Ligelizumab...
5 KB (560 words) - 00:25, 17 July 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
27 KB (2,274 words) - 02:54, 22 March 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
50 KB (6,087 words) - 07:46, 26 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
3 KB (292 words) - 18:49, 24 February 2024
for IPF, including the monoclonal antibodies simtuzumab, tralokinumab, lebrikizumab and FG-3019, a lysophosphatidic acid receptor antagonist (BMS-986020)...
71 KB (7,916 words) - 07:04, 27 August 2024
Cintredekin besudotox Interleukin 4 Interleukin 13 Antibodies: Anrukinzumab Lebrikizumab Tralokinumab IL-15 Agonists: ALT-803 Interleukin 15 IL-17 Agonists: Interleukin...
34 KB (2,690 words) - 02:57, 26 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
57 KB (5,584 words) - 21:17, 23 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
50 KB (4,379 words) - 21:52, 16 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
3 KB (192 words) - 00:44, 9 June 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
11 KB (692 words) - 05:26, 15 September 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
15 KB (1,266 words) - 05:55, 14 May 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
34 KB (3,039 words) - 08:54, 4 June 2024
Omalizumab Interferon Faralimomab IL-6 Elsilimomab IL-12, IL-13, and IL-23 Lebrikizumab Ustekinumab IL-17A Secukinumab Cellular target CD3 Muromonab-CD3 Otelixizumab...
7 KB (299 words) - 13:45, 27 April 2024
Glycopyrronium tosylate Hyaluronic acid Hydrogen peroxide Ivermectin Lebrikizumab Lokivetmab Magnesium sulfate Metandienone Nemolizumab Oclacitinib Oxymetazoline...
25 KB (2,427 words) - 13:46, 7 September 2024